Debra A. Bronder
CIK 1407951 · View on SEC EDGAR ↗
First SEC filing: Aug. 5, 2019 · Latest: Aug. 5, 2019
On this page
Insider at
Insider transactions
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
No open-market trades on record; showing all filings.
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| Feb. 23, 2021 | VYX | A | 6,354 | $35.41 | $224,995 | 67,123 Direct | +10.46% | Acquired | -64.8% (price as of 2026-08-20) |
| Feb. 8, 2021 | VYX | M | 22,907 | — | — | 22,907 Direct | — | Acquired | (price as of 2026-08-20) |
| Feb. 8, 2021 | VYX | F | 7,038 | $37.68 | $265,192 | 60,769 Direct | -10.38% | Disposed | -66.9% (price as of 2026-08-20) |
| Feb. 8, 2021 | VYX | M | 22,904 | — | — | 67,807 Direct | +51.01% | Acquired | (price as of 2026-08-20) |
| Aug. 1, 2020 | VYX | F | 5,529 | $18.43 | $101,899 | 44,903 Direct | -10.96% | Disposed | -32.4% (price as of 2026-08-20) |
| Feb. 12, 2020 | VYX | A | 124,204 | — | — | 124,204 Direct | — | Acquired | (price as of 2026-08-20) |
| Feb. 8, 2020 | VYX | M | 45,811 | — | — | 45,811 Direct | — | Acquired | (price as of 2026-08-20) |
| Feb. 8, 2020 | VYX | F | 7,019 | $33.20 | $233,031 | 49,652 Direct | -12.39% | Disposed | -62.5% (price as of 2026-08-20) |
| Feb. 8, 2020 | VYX | M | 22,904 | — | — | 56,671 Direct | +67.83% | Acquired | (price as of 2026-08-20) |
| Aug. 1, 2019 | VYX | F | 3,923 | $32.98 | $129,381 | 33,767 Direct | -10.41% | Disposed | -62.2% (price as of 2026-08-20) |
| Feb. 8, 2019 | VYX | A | 65,136 | — | — | 65,136 Direct | — | Acquired | (price as of 2026-08-20) |
| Aug. 1, 2018 | VYX | A | 36,778 | $27.19 | $999,994 | 36,778 Direct | — | Acquired | -54.2% (price as of 2026-08-20) |
| Aug. 1, 2018 | VYX | A | 59,595 | — | — | 59,595 Direct | — | Acquired | (price as of 2026-08-20) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II)
Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| Feb. 8, 2021 | VYX | Restricted Stock Units | Common Stock (22,907) | — | — | 22,907 | Acquired |
| Feb. 12, 2020 | VYX | Employee Stock Option (Right to Buy) | Common Stock (124,204) | — | Feb. 12, 2027 | 124,204 | Acquired |
| Feb. 8, 2020 | VYX | Restricted Stock Units | Common Stock (45,811) | — | — | 45,811 | Acquired |
| Feb. 8, 2019 | VYX | Employee Stock Option (Right to Buy) | Common Stock (65,136) | $26.42 | Feb. 8, 2026 | 65,136 | Acquired |
| Aug. 1, 2018 | VYX | Employee Stock Option (Right to Buy) | Common Stock (59,595) | $27.19 | July 31, 2025 | 59,595 | Acquired |
Exercise/conversion price is blank when not applicable (e.g. RSUs).